Cambridge drugmaker Moderna joins the Ebola vaccine race

Moderna joins race for Ebola vaccine as Bundibugyo strain spreads in Africa

Moderna partners with CEPI on Ebola vaccine efforts amid outbreak in Africa

Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting

Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus

Moderna (MRNA) Expands Vaccine Collaboration to Combat Bundibugy

Moderna and other groups get $60 million to develop Ebola vaccine

Moderna, Inc. (MRNA) Stock Analysis: Evaluating a Biotech Powerhouse with a -8.46% Potential Downside

Moderna, Inc. $MRNA Position Reduced by Legal & General Group Plc

Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus

Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus

Moderna backs new Ebola vaccine as CEPI commits up to $50M

Moderna-Merck skin cancer treatment shows long-term benefits

Moderna (MRNA) CFO vests RSUs and withholds 533 shares to cover taxes

Moderna (MRNA) Chief Legal Officer reports RSU vesting and tax-share withholdings

Moderna (MRNA) president logs RSU vesting and tax-withholding share dispositions

FDA panel backs XFG strain for 2026-27 COVID vaccine update (MRNA:NASDAQ)

WITTENBERG INVESTMENT MANAGEMENT, INC.'s Moderna Inc(MRNA) Holding History